Aldesleukin (Clinigen Healthcare)

N/A

Report date: 2023/05/08 13:55:25

Base Information

Drug NameAldesleukin (Clinigen Healthcare)
Drug Alias Name阿地白介素
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonistsImmunostimulants
TargetsInterleukin-2 receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesClinigen Healthcare LtdSuzhou Grit Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClinigen Healthcare Ltd
Inactive CompaniesSuzhou Grit Biotechnology Co Ltd
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG